Selected Milestones Of FDA Regulation Of Nonprescription Drugs
This article was originally published in The Tan Sheet
Since Congress in 1962 passed legislation requiring pre-market approval of OTCs, the agency has marked many milestones in its oversight of nonprescription drugs development and manufacturing.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.